Skip to main content
Sinovac reports positive data from Phase I/II trials of CoronaVac - Clinical Trials Arena 16-Jun-2020

Sinovac reports positive data from Phase I/II trials of CoronaVac - Clinical Trials Arena
China-based Sinovac Biotech has reported positive preliminary data from the Phase I/II clinical trials of its Covid-19 vaccine candidate, CoronaVac.
More...